相关实验视频
Updated: Jan 14, 2026

03:37
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
5.1K
为了改善精神分裂症管理的治疗结果,先进的纳米粒子启用的Risperidone交付:一篇评论
Ashwin Kumar1, Mahesha Keerikkadu2, Pragathi Devanand Bangera2
1Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
Drug development and industrial pharmacy
|October 23, 2025
概括
含有Risperidone (RSP) 的纳米粒子通过改善药物输送,为精神分裂症 (SZ) 管理提供了一个有希望的方法. 这些纳米载体提高了疗效,减少了副作用,使得患有这种精神障碍的患者受益.
科学领域:
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 精神分裂症 (SZ) 需要长期治疗,通常是用Risperidone (RSP).
- 由于溶解性差,生物可用性低以及副作用,RSP的有效性受到限制.
- 纳米技术提供了新的药物输送系统来克服这些局限性.
研究的目的:
- 审查瑞斯佩里 (RSP) 装载纳米粒子治疗精神分裂症 (SZ) 的治疗潜力.
- 评估纳米载体系统,以改善药物输送,疗效和患者的治疗结果.
主要方法:
- 对装有RSP的纳米粒子 (聚合物,固体脂质,纳米结构脂质) 的临床前数据的审查.
- 药物加载效率的评估,释放动力学,脑向和施用路径.
主要成果:
- RSP纳米颗粒显示出增强的溶解性,持续释放,以及改进的大脑准.
- 鼻内和肠外途径显示增加了生物可用性和遵从性.
- 配方降低了全身毒性和额外金字塔症状.
结论:
- 装有RSP的纳米粒子代表了SZ疗法的重大进步.
- 这些系统提高了疗效,最大限度地减少了副作用,并提高了患者的服从性.
- 需要进一步的临床研究来确定安全性,长期疗效和商业可行性.
相关概念视频
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239
Psychosis: Goals of Pharmacotherapy
466
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
466
Psychosis and Antipsychotic Drugs: Overview
811
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
811
Antipsychotic Drugs: Typical and Atypical Agents
746
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
746
Drug Delivery: Miscellaneous Routes
708
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
708
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249

